Schistosomiasis (Bilharzia) is the second most lethal parasitic worm disease, infecting approximately 207 million people and causing 280,000 deaths annually worldwide. Thanks to generous donations from Mort and Chris Hyman and Mr. Len Blavatnik, trustee at the Blavatnik Charitable Foundation, the Schistosomiasis Vaccine Program is becoming a reality.
WASHINGTON, DC, January 26, 2005—Clinical trials to test the safety of a first-of-its-kind human hookworm vaccine will begin in the Washington, DC area in a couple of months after the U.S. Food and Drug Administration conferred investigational new drug status on the vaccine.
New England Journal of Medicine Article Illuminates Latest Findings on Bloodthirsty Parasite
NEW CANAAN, CT, August 19, 2004—An article published today in The New England Journal of Medicine calls attention to the enormous impact of parasitic hookworm infection on the developing world poor. The authors of “Current Concepts: Hookworm Infection” have studied the parasite over many years and describe the disturbing effects of mild infection as well as the disease state that results from heavy hookworm infection.